Results 291 to 300 of about 1,998,001 (374)

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Latest Updates and Challenges in infections in intensive care medicine. [PDF]

J Intensive Med
Rello J.
europepmc   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source

Recommendations for the College of Intensive Care Medicine (CICM) trainee research project: A modified Delphi study. [PDF]

Crit Care Resusc
Ho A, Denny KJ, Laupland KB, Ramanan M, Tabah A, McCullough J, Schults JA, Raman S, members of the Queensland Critical Care Research Network.   +8 more
europepmc   +1 more source

Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma

Arthritis Care &Research, EarlyView.
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source

Global and Regional Temporal Changes in Cross‐Country Inequalities of Site‐Specific Osteoarthritis Burden, 1990 to 2021

Arthritis Care &Research, EarlyView.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rates (ASYRs) for site‐specific OA across 204 countries and territories were obtained from the Global Burden of Diseases, Injuries, and ...
Haowei Chen, Lei Si, David J. Hunter, Lei Zhang, Zhe‐Sheng Chen, Xiaomeng Wang, Vicky Duong, Zhounan Zhou, Peihua Cao, Han Cen, Su'an Tang, Tianyu Chen, Houjun Xue, Zhaohua Zhu, Changhai Ding   +14 more
wiley   +1 more source

Contribution of Open Access Databases to Intensive Care Medicine Research: Scoping Review.

J Med Internet Res
Kallout J, Lamer A, Grosjean J, Kerdelhué G, Bouzillé G, Clavier T, Popoff B.   +6 more
europepmc   +1 more source

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

Arthritis Care &Research, EarlyView.
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls   +16 more
wiley   +1 more source

Long-term mortality of Dutch COVID-19 patients admitted to the intensive care medicine: a retrospective analysis from a national quality registry. [PDF]

Crit Care Sci
Wortel SA, Bakhshi-Raiez F, Abu-Hanna A, Dongelmans DA, Keizer NF, Dutch COVID-19 Research Consortium, Houwink A, Dijkhuizen A, Draisma A, Rijkeboer A, Cloïn A, Meijer A, Reidinga A, Festen-Spanjer B, van Bussel B, Eikemans B, Jacobs C, Moolenaar D, Ramnarain D, Koning D, Boer D, Verbiest D, van Slobbe-Bijlsma E, van Koppen E, Rengers E, van Driel E, Verweij E, van Iersel F, Brunnekreef G, Kieft H, Kreeftenberg H, Hené I, Janssen I, Drogt I, van der Horst I, Spijkstra JJ, Rozendaal J, Mehagnoul-Schipper J, Erasmus JE, Holtkamp J, Lutisan J, van Oers J, Lens J, van Gulik L, van den Berg L, Urlings-Strop L, Georgieva L, van Lieshout M, Hoogendoorn M, Mos MV, Graaff M, Bruin M, Hoeksema M, van Tellingen M, Barnas M, Erkamp M, Gritters N, Kusadasi N, Elbers P, Koetsier P, Spronk P, van der Voort P, Pruijsten R, Jong R, Bosman RJ, Wesselink R, Schnabel R, van den Berg R, Waal R, Arbous S, Knape S, Hendriks S, Frenzel T, Dormans T, Rijpstra T, Silderhuis V, Ruijter W.   +76 more
europepmc   +1 more source

Received an encouragement award 2023 from the Japanese Society of Intensive Care Medicine

Kazuya Kikutani
openalex   +2 more sources